Tamarack Advisers’s CareDx CDNA Stock Holding History

Tamarack Advisers’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30,000	Closed	-$342K	–	42
2022 Q4	$342K	Buy	30,000 +5,000	+20%	+$74.1K	0.18%	34
2022 Q3	$426K	Hold	25,000	–	–	0.25%	40
2022 Q2	$537K	Buy	+25,000	New	+$693K	0.31%	35

Other funds holding CDNA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Tamarack Advisers's CDNA Position: Q1 2023 in Review

Tamarack Advisers sold out of CareDx (CDNA) in Q1 2023, closing a stake of 30,000 shares — an estimated $342K sold.

Tamarack Advisers first reported a position in CDNA in Q2 2022 and held it in 3 quarters. The position peaked at $537K in Q2 2022. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

Tamarack Advisers reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
Tamarack Advisers sold 30,000 CareDx shares in Q1 2023, an estimated $342K.
Tamarack Advisers first reported a position in CareDx in Q2 2022 and held it in 3 quarters.
Tamarack Advisers's CareDx position peaked at $537K in Q2 2022.
156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on Tamarack Advisers's 13F filing for Q1 2023, filed 11 May 2023.